• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Aug 19, 2015 4:33 PM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

Why to Buy These 5 Under-$10 Stocks ASAP

  • By Roberto Pedone
  • Aug 20, 2014 6:00 AM EDT
Stocks Are Slightly Lower as First-Quarter GDP, Chicago PMI Decline
MARKETS

Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline

  • By Jane Searle
  • Mar 24, 2014 4:14 PM EDT
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

22 Biotech Stock Predictions for 2014

  • By Adam Feuerstein
  • Jan 6, 2014 7:58 AM EST
5 Stocks Under $10 Set to Soar
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Sep 26, 2013 2:33 PM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

7 Under-$10 Stocks Racing Higher

  • By Roberto Pedone
  • Sep 11, 2013 8:30 AM EDT
5 Heavily Shorted Stocks Set to Soar on Bullish Earnings
INVESTING

3 Biotech Stocks Under $10 to Trade for Breakouts

  • By Roberto Pedone
  • Jul 31, 2013 8:03 AM EDT
Top Insider Trades: AON OPK RGDO MBRG
STOCKS

Top Insider Trades: AEGR VVTV CCO ALXA

  • By Jonathan Moreland
  • Jan 23, 2013 8:59 AM EST
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

5 Stocks With Big Insider Buying

  • By Roberto Pedone
  • Jan 2, 2013 11:33 AM EST
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

13 Biotech Stock Predictions for 2013

  • By Adam Feuerstein
  • Jan 2, 2013 6:00 AM EST
Stock Markets Grind Higher as Apple Gains on Watch Sales
STOCKS

Stocks to Watch: Regions, Google, RIM

  • By Joseph Woelfel
  • Dec 24, 2012 5:48 AM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Shorting Alexza Pharma On FDA's Adasuve Approval

  • By Mark Messier
  • Dec 19, 2012 7:00 AM EST
Stocks Socked Despite Upbeat China Numbers; Apple Falls
MARKETS

Stocks Socked Despite Upbeat China Numbers; Apple Falls

  • By Andrea Tse
  • Dec 14, 2012 4:29 PM EST
The Next Big Thing in Biotech: FDA Decisions
VIDEO

The Next Big Thing in Biotech: FDA Decisions

  • By Adam Feuerstein
  • Dec 14, 2012 5:30 AM EST
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

Alexza Pharma: Premium Selling Options Strategy

  • By Tony Pelz
  • Dec 12, 2012 11:27 AM EST
FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

  • By Mark Messier
  • Nov 20, 2012 8:03 AM EST
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

21 Most Volatile Biopharma Stocks Closing Out 2012

  • By Adam Feuerstein
  • Nov 5, 2012 6:00 AM EST
5 Stocks Insiders Love Right Now
INVESTING

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Oct 5, 2012 1:13 PM EDT
5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More
INVESTING

3 Health Care Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Oct 2, 2012 2:35 PM EDT
Buy Rated Semiconductors Lag the SOX
MARKETS

8 Stocks Under $10 Surging Higher

  • By Roberto Pedone
  • Aug 28, 2012 2:19 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

31 Drugs Facing FDA Approval in 2012-2013

  • By Adam Feuerstein
  • Aug 20, 2012 8:00 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Aug 16, 2012 1:11 PM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Alexza Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Aug 10, 2012 7:25 PM EDT
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

28 Drugs Facing FDA Approval in 2012-2013

  • By Adam Feuerstein
  • Jul 24, 2012 7:38 AM EDT
Stocks Begin 2014 With Inflating Bubbles
MARKETS

7 Stocks Under $10 With Relative Strength

  • By Roberto Pedone
  • Jun 25, 2012 2:36 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.